Author name: indiafightstb_2023

Transforming TB care by collaborating with private sector for better outcomes

Tuberculosis remains one of the world’s deadliest infectious diseases, claiming 1.5 million lives annually despite being preventable and curable. Every year, 10 million people fall ill with TB, with low- and middle-income countries bearing the brunt of the epidemic, particularly Bangladesh, China, India, Indonesia, Nigeria, Pakistan, Philippines and South Africa. The alarming reality is that […]

Transforming TB care by collaborating with private sector for better outcomes Read More »

Preventing TB among India’s Tibetan refugee children: Successes and challenges

Tuberculosis poses a pressing threat to Tibetan refugee children and adolescents in Indian boarding schools. The alarming reality: 1.8 million Indians suffered from TB in 2022 (WHO), with children under 15 accounting for 12% of reported cases (Central TB Division). To combat this, the pioneering Zero TB Kids Project launched an ambitious screening and preventive

Preventing TB among India’s Tibetan refugee children: Successes and challenges Read More »

Breathing Life into TB Prevention: Essential Environments and Resources

Tuberculosis (TB) has emerged as the world’s second deadliest infectious disease, following COVID-19. The COVID-19 pandemic severely impacted TB prevention and treatment efforts, leading to an estimated half a million excess deaths between 2020 and 2022. While there has been some recovery in TB diagnosis and treatment post-pandemic, the disease remains a significant concern, particularly

Breathing Life into TB Prevention: Essential Environments and Resources Read More »

TB Immunity Research Paves the Way for Innovative Therapies and Prevention Strategies

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (MTB), remains a formidable global health challenge. As of 2022, TB was the second leading infectious killer worldwide, claiming 1.3 million lives, following COVID-19. Despite medical advancements, TB continues to pose significant problems due to rising drug resistance and the demands of prolonged treatment regimens. Following a

TB Immunity Research Paves the Way for Innovative Therapies and Prevention Strategies Read More »

Scroll to Top